S8 Ep31: Breast Cancer Experts Review 2023 MBCC Research Updates and the Importance of Multidisciplinary Collaboration

1

Introduction

00:00 • 2min

2

The Transition From Adjuvant Trials to New Adjuvate Trials in Patients With High Risk Breast Cancer

02:02 • 2min

3

The Importance of Early Endpoints in Tumor Therapy

03:34 • 2min

4

iSpy 2: A Platform Trial

05:49 • 2min

5

The Effect of Hormone Receptor Positive Therapy on Tumor Response Rates

07:25 • 2min

6

The Future of Clinical Trials

09:20 • 3min

7

The Importance of Platform Trials in Breast Cancer Treatment

12:14 • 2min

8

Axillary Reverse Mapping for the Prevention of Lymphoma and Breast Cancer

13:58 • 2min

9

The Importance of Axislary Reverse Mapping

15:30 • 2min

10

The Importance of Axislary Reverse Mapping in the Prevention of Lymphoma

17:42 • 2min

11

How to Increase Identification Rates in Breast Cancer Surgery

20:10 • 2min

12

Sequencing Therapy for Metastatic Triple Negative Breast Cancer

21:48 • 2min

13

The Role of Next Gen Sequencing in Breast Cancer

24:08 • 2min

14

The Unmet Needs of Tumors in the Treatment Landscape

26:01 • 2min

15

How Response Guided Therapy Can Be Used to Personalized Breast Cancer Treatment

27:49 • 2min

16

Response Guided Therapy and Her Two Positive Breast Cancer

29:23 • 2min

17

The Importance of Response Guided Therapy for Breast Cancer

31:04 • 2min

18

The Future of Response Guided Therapy for Early Breast Cancer

32:43 • 2min

19

Antibody Drug Conjugates for HER2DX Negative Metastatic Disease

34:16 • 2min

20

The Impact of the Energy BRO2 Trial on Local Therapy for Metastatic Breast Cancer

36:12 • 2min

21

The Negative Trial in Metastatic Disease

38:21 • 2min

22

The Importance of Hosting Conferences and Gatherings Like This

40:13 • 3min